Abstract
Has effects on both dopamine and serotonin receptors. Approved by the FDA for the treatment of both schizophrenia and bipolar disorder, it can be taken by mouth once daily, with or without food. The recommended dose for schizophrenia is 1.5–6 mg/day and for bipolar disorder 3–6 mg/day.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Behere, P.B., Das, A., Behere, A.P. (2019). Upcoming Medicines. In: Clinical Psychopharmacology. Springer, Singapore. https://doi.org/10.1007/978-981-13-2092-7_11
Download citation
DOI: https://doi.org/10.1007/978-981-13-2092-7_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2091-0
Online ISBN: 978-981-13-2092-7
eBook Packages: MedicineMedicine (R0)